| Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis BE Sands, L Peyrin-Biroulet, EV Loftus Jr, S Danese, JF Colombel, ... New England Journal of Medicine 381 (13), 1215-1226, 2019 | 657 | 2019 |
| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172-179, 2015 | 343 | 2015 |
| European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients OP Nyssen, D Bordin, B Tepes, Á Pérez-Aisa, D Vaira, M Caldas, ... Gut 70 (1), 40-54, 2021 | 225 | 2021 |
| Perceptual and acoustic characteristics of voice changes in reflux laryngitis patients R Pribuisiene, V Uloza, L Kupcinskas, L Jonaitis Journal of Voice 20 (1), 128-136, 2006 | 167 | 2006 |
| Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized … L Kupcinskas, P Lafolie, Å Lignell, G Kiudelis, L Jonaitis, K Adamonis, ... Phytomedicine 15 (6-7), 391-399, 2008 | 123 | 2008 |
| Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort Z Vegh, J Burisch, N Pedersen, I Kaimakliotis, D Duricova, M Bortlik, ... Journal of Crohn's and Colitis 8 (11), 1506-1515, 2014 | 120 | 2014 |
| Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study R Zykus, L Jonaitis, V Petrenkienė, A Pranculis, L Kupčinskas BMC gastroenterology 15, 1-7, 2015 | 112 | 2015 |
| Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study J Burisch, H Vardi, D Schwartz, M Friger, G Kiudelis, J Kupčinskas, ... The lancet Gastroenterology & hepatology 5 (5), 454-464, 2020 | 109 | 2020 |
| Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort J Burisch, N Pedersen, S Cukovic-Cavka, N Turk, I Kaimakliotis, ... Inflammatory bowel diseases 20 (1), 36-46, 2014 | 106 | 2014 |
| The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology M Leja, L Kupcinskas, K Funka, A Sudraba, L Jonaitis, A Ivanauskas, ... Digestive diseases and sciences 54, 2377-2384, 2009 | 103 | 2009 |
| Randomised clinical trial: a comparative dose‐finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis W Kruis, L Jonaitis, J Pokrotnieks, TL Mikhailova, M Horynski, M Bátovský, ... Alimentary pharmacology & therapeutics 33 (3), 313-322, 2011 | 91 | 2011 |
| Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel … J Burisch, P Weimers, N Pedersen, S Cukovic-Cavka, B Vucelic, ... Journal of Crohn's and Colitis 8 (9), 1030-1042, 2014 | 90 | 2014 |
| Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer J Kupcinskas, T Wex, A Link, M Leja, I Bruzaite, R Steponaitiene, ... PloS one 9 (1), e87467, 2014 | 87 | 2014 |
| Efficacy of per-oral methylene blue formulation for screening colonoscopy A Repici, MB Wallace, JE East, P Sharma, FC Ramirez, DH Bruining, ... Gastroenterology 156 (8), 2198-2207. e1, 2019 | 81 | 2019 |
| Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer J Kupcinskas, I Bruzaite, S Juzenas, U Gyvyte, L Jonaitis, G Kiudelis, ... Scientific reports 4 (1), 5993, 2014 | 80 | 2014 |
| Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori … J Kupcinskas, T Wex, J Bornschein, M Selgrad, M Leja, E Juozaityte, ... BMC medical genetics 12, 1-9, 2011 | 80 | 2011 |
| Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study A Mickevičius, Ž Endzinas, M Kiudelis, L Jonaitis, L Kupčinskas, ... Surgical endoscopy 22, 2269-2276, 2008 | 78 | 2008 |
| Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin LP Andersen, S Holck, L Kupcinskas, G Kiudelis, L Jonaitis, ... FEMS Immunology & Medical Microbiology 50 (2), 244-248, 2007 | 73 | 2007 |
| Adverse event profile during the treatment of Helicobacter pylori: a real-world experience of 22,000 patients from the European registry on H. pylori management (Hp-EuReg) OP Nyssen, A Perez-Aisa, B Tepes, M Castro-Fernandez, J Kupcinskas, ... Official journal of the American College of Gastroenterology| ACG 116 (6 …, 2021 | 62 | 2021 |
| Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study J Burisch, H Vardi, N Pedersen, M Brinar, S Cukovic-Cavka, I Kaimakliotis, ... Inflammatory bowel diseases 21 (1), 121-131, 2015 | 62 | 2015 |
Limas KupcinskasProf.MD,PhD, Department of Gastroenterology, Lithuanian University of Health Sciences在 lsmu.lt 的电子邮件经过验证
